ReSuture, Inc. Awarded $996,413 NSF Phase II Small Business Innovation Research Grant to Support Surgical Performance and Medical Device Development
The grant will support commercialization of ReSuture's products and technology to evaluate vascular surgical operative performance in both open and endovascular fields.
- The grant will support commercialization of ReSuture's products and technology to evaluate vascular surgical operative performance in both open and endovascular fields.
- The grant, entitled "SBIR Phase II: Quantification of Operative performance through Simulated Surgical Platforms, Capacitive Sensing, and Machine Learning to Improve Surgeon Performance and Medical Device Development," will be conducted in conjunction with Arizona State University (ASU).
- Gore, Teleflex Medical, Becton Dickinson, Endologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic.
- This NSF Phase II funding represents a tremendous opportunity for further development and commercial scaling of our products that can improve surgical training and revolutionize development pipelines in the medical device industry.